Clinical Trial Update: R-MVST Cells for Treatment of Viral Infections [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating R-MVST cells for the treatment of viral infections, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infection
• Bk Virus Infection
• Cytomegalovirus Infection
• Epstein-barr Virus Infection

Drugs mentioned

• R-MVST Cells (R-MVST cells)

Snippet

Sponsor: Columbia University | Conditions: Epstein-Barr Virus Infections, Cytomegalovirus Infections | Phase 1 | Status: RECRUITING